Drug intelligence / Profile preview

Nicomide

Development stage
Unknown
Lead developer
Avion Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Nicomide is a prescription dietary supplement combination containing nicotinamide (niacinamide), zinc oxide, cupric oxide (copper), and folic acid. It is specifically formulated for the dietary management of inflammatory skin disorders, most notably acne vulgaris and rosacea. The product works through a multi-faceted approach: nicotinamide and zinc provide potent anti-inflammatory effects, with zinc also potentially regulating sebum production. Folic acid is included to support cellular health and DNA synthesis, while copper is added to the formulation to prevent the potential for zinc-induced copper deficiency. Developed and manufactured by Avion Pharmaceuticals, Nicomide is available as an oral tablet and is intended for patients who are deficient in or at risk of deficiency in these specific nutrients.

Other names
nicotinamide + zinc + copper + folic acidniacinamide + zinc + copper + folic acid
02

Targets

NF-κBPARP1 (Poly (adp-ribose) polymerase 1)DNA

Beyond the preview

Go deeper on Nicomide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicomide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call